PROGNOSTIC EVALUATION OF PATIENTS WITH LUMINAL B IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE FROM 2006 TO 2014

Authors

  • Fábio F. O. Rodrigues Dr. Arnaldo Vieira de Carvalho Cancer Institute
  • Eveline A. Silva Dr. Arnaldo Vieira de Carvalho Cancer Institute
  • Etienne A. Bastos Dr. Arnaldo Vieira de Carvalho Cancer Institute
  • Daniel C. B. de Oliveira Dr. Arnaldo Vieira de Carvalho Cancer Institute
  • Rodrigo M. Silva Dr. Arnaldo Vieira de Carvalho Cancer Institute
  • Carlos E. Fristachi Dr. Arnaldo Vieira de Carvalho Cancer Institute

DOI:

https://doi.org/10.29289/259453942019v29s1ep28

Downloads

Download data is not yet available.

Author Biography

Fábio F. O. Rodrigues, Dr. Arnaldo Vieira de Carvalho Cancer Institute

Oncoginecology and Mastology Service, Dr Arnaldo. Vieira de Carvalho Cancer Institute

Downloads

Published

2019-09-29

How to Cite

Rodrigues, F. F. O., Silva, E. A., Bastos, E. A., Oliveira, D. C. B. de, Silva, R. M., & Fristachi, C. E. (2019). PROGNOSTIC EVALUATION OF PATIENTS WITH LUMINAL B IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE FROM 2006 TO 2014. Mastology, 29(3), 59. https://doi.org/10.29289/259453942019v29s1ep28

Issue

Vol. 29 No. 3 (2019): Supplement 1

Section

E-poster

License

Copyright (c) 2019 Fábio F. O. Rodrigues, Eveline A. Silva, Etienne A. Bastos, Daniel C. B. de Oliveira, Rodrigo M. Silva, Carlos E. Fristachi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.